Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.

James SH, Price NB, Hartline CB, Lanier ER, Prichard MN.

Antimicrob Agents Chemother. 2013 Jul;57(7):3321-5. doi: 10.1128/AAC.00062-13. Epub 2013 May 6.

3.

Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.

Fischer L, Sampaio KL, Jahn G, Hamprecht K, Göhring K.

J Clin Virol. 2015 Aug;69:150-5. doi: 10.1016/j.jcv.2015.06.090. Epub 2015 Jun 19.

PMID:
26209398
4.

Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.

Scott GM, Weinberg A, Rawlinson WD, Chou S.

Antimicrob Agents Chemother. 2007 Jan;51(1):89-94. Epub 2006 Oct 16.

5.

Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.

Chou S, Marousek G, Bowlin TL.

Antimicrob Agents Chemother. 2012 Jan;56(1):197-201. doi: 10.1128/AAC.05559-11. Epub 2011 Oct 3.

6.

Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.

Fischer L, Laib Sampaio K, Jahn G, Hamprecht K, Göhring K.

Antiviral Res. 2013 Dec;100(3):575-7. doi: 10.1016/j.antiviral.2013.09.026. Epub 2013 Oct 10.

PMID:
24120366
7.
8.

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.

Drew WL, Miner RC, Marousek GI, Chou S.

J Clin Virol. 2006 Oct;37(2):124-7. Epub 2006 Sep 8.

PMID:
16962820
9.

Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.

Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M.

J Med Virol. 2008 Oct;80(10):1769-75. doi: 10.1002/jmv.21277.

PMID:
18712833
10.

Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus.

Chou S, Marousek G, Li S, Weinberg A.

J Clin Virol. 2008 Sep;43(1):107-9. doi: 10.1016/j.jcv.2008.04.005. Epub 2008 May 27.

12.

Antiviral drug resistance of human cytomegalovirus.

Lurain NS, Chou S.

Clin Microbiol Rev. 2010 Oct;23(4):689-712. doi: 10.1128/CMR.00009-10. Review.

13.

Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.

Chou S.

J Clin Virol. 2011 Apr;50(4):287-91. doi: 10.1016/j.jcv.2011.01.004. Epub 2011 Feb 3.

14.

Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.

Scott GM, Ng HL, Morton CJ, Parker MW, Rawlinson WD.

J Gen Virol. 2005 Aug;86(Pt 8):2141-51.

PMID:
16033961
15.

Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.

Mousavi-Jazi M, Schloss L, Drew WL, Linde A, Miner RC, Harmenberg J, Wahren B, Brytting M.

J Clin Virol. 2001 Dec;23(1-2):1-15.

PMID:
11595579
16.
17.

Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.

Göhring K, Wolf D, Bethge W, Mikeler E, Faul C, Vogel W, Vöhringer MC, Jahn G, Hamprecht K.

J Clin Virol. 2013 May;57(1):43-9. doi: 10.1016/j.jcv.2013.01.003. Epub 2013 Jan 30.

PMID:
23375740
18.

Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.

Chou S, Ercolani RJ, Sahoo MK, Lefterova MI, Strasfeld LM, Pinsky BA.

Antimicrob Agents Chemother. 2014 Aug;58(8):4697-702. doi: 10.1128/AAC.03214-14. Epub 2014 Jun 2.

20.

Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.

Scott GM, Isaacs MA, Zeng F, Kesson AM, Rawlinson WD.

J Med Virol. 2004 Sep;74(1):85-93.

PMID:
15258973

Supplemental Content

Support Center